-
Tytuł:
-
Personality disorder increases risk of low quality of life among women with mental state disorders.
-
Autorzy:
-
Kavanagh BE; Deakin University, Institute for Physical and Mental Health and Clinical Translation School of Medicine, Barwon Health, Geelong, Victoria, Australia.. Electronic address: .
Stuart AL; Deakin University, Institute for Physical and Mental Health and Clinical Translation School of Medicine, Barwon Health, Geelong, Victoria, Australia.. Electronic address: .
Berk M; Deakin University, Institute for Physical and Mental Health and Clinical Translation School of Medicine, Barwon Health, Geelong, Victoria, Australia.; Florey Institute for Neuroscience and Mental Health, the University of Melbourne, Parkville, Victoria, Australia; The University of Melbourne, Department of Psychiatry, Royal Melbourne Hospital, Parkville, Victoria, Australia; Orygen, Melbourne, Victoria, Australia; Centre for Youth Mental Health, the University of Melbourne, Parkville, Victoria, Australia; Barwon Health, Geelong, Victoria, Australia; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia. Electronic address: .
Turner A; Deakin University, Institute for Physical and Mental Health and Clinical Translation School of Medicine, Barwon Health, Geelong, Victoria, Australia.; School of Medicine and Public Health, Faculty of Health and Medicine, the University of Newcastle, Callaghan, New South Wales, Australia. Electronic address: .
Dean OM; Deakin University, Institute for Physical and Mental Health and Clinical Translation School of Medicine, Barwon Health, Geelong, Victoria, Australia.; Florey Institute for Neuroscience and Mental Health, the University of Melbourne, Parkville, Victoria, Australia. Electronic address: .
Pasco JA; Deakin University, Institute for Physical and Mental Health and Clinical Translation School of Medicine, Barwon Health, Geelong, Victoria, Australia.; Barwon Health, Geelong, Victoria, Australia; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia; Department of Medicine - Western Health, the University of Melbourne, St Albans, Victoria, Australia. Electronic address: .
Jackson HJ; The University of Melbourne, Melbourne School of Psychological Sciences, Parkville, Victoria, Australia. Electronic address: .
Koivumaa-Honkanen H; Institute of Clinical Medicine (Psychiatry), University of Eastern Finland, Kuopio, Finland; Departments of Psychiatry: Kuopio University Hospital, Kuopio; South-Savonia Hospital District, Mikkeli; Siunsote, Joensuu; Ylä-Savon SOTE, Iisalmi, Finland; Department of Psychiatry, Oulu University Hospital, Finland. Electronic address: .
Chanen AM; Orygen, Melbourne, Victoria, Australia; Centre for Youth Mental Health, the University of Melbourne, Parkville, Victoria, Australia. Electronic address: .
Williams LJ; Deakin University, Institute for Physical and Mental Health and Clinical Translation School of Medicine, Barwon Health, Geelong, Victoria, Australia.. Electronic address: .
-
Źródło:
-
Comprehensive psychiatry [Compr Psychiatry] 2020 Oct; Vol. 102, pp. 152193. Date of Electronic Publication: 2020 Jul 12.
-
Typ publikacji:
-
Journal Article; Research Support, Non-U.S. Gov't
-
Język:
-
English
-
Imprint Name(s):
-
Publication: Philadelphia Pa : W.B. Saunders
Original Publication: New York.
-
MeSH Terms:
-
Mental Disorders*
Quality of Life*
Anxiety ; Diagnostic and Statistical Manual of Mental Disorders ; Female ; Humans ; Personality Disorders/diagnosis ; Personality Disorders/epidemiology ; Surveys and Questionnaires
-
Contributed Indexing:
-
Keywords: Epidemiology; Mental state disorders; Personality disorders; Quality of life; Women
-
Entry Date(s):
-
Date Created: 20200731 Date Completed: 20201221 Latest Revision: 20201221
-
Update Code:
-
20240104
-
DOI:
-
10.1016/j.comppsych.2020.152193
-
PMID:
-
32730960
-
Background: Limited data are available examining the relationship between mental state disorders (mood, anxiety, substance use, eating disorders), their co-occurrence with personality disorder (PD), and quality of life among women. We aimed to investigate these relationships in a sample of women from the community.
Method: Women from the Geelong Osteoporosis Study (n = 717) were administered the Structured Clinical Interview for DSM-IV (SCID-I/NP and SCID-II) and the World Health Organisation Quality of Life scale (WHOQOL-BREF). Weight and height were measured and lifestyle and demographic factors were self-reported. Logistic regression models (odds ratios with 95% confidence intervals) were undertaken to investigate associations among groups (mental state disorders, co-occurring mental state disorders with PD, and controls) and the WHOQOL-BREF domains (physical, psychological, social, and environmental health) while testing for potential confounding.
Results: Results indicated that mental state disorders were associated with increased risk of low quality of life in physical, psychological, social, but not environmental domains, compared to controls. This risk was increased among women with co-occurring PD across all domains compared to both controls and those with mental state disorders.
Conclusion: These findings add evidence suggesting poor quality of life is experienced by those with mental state disorders, and that this is worsened by the experience of co-occurring PD.
Competing Interests: Declaration of Competing Interest OMD has received grant support from the Brain and Behavior Foundation, Simons Autism Foundation, Stanley Medical Research Institute, Deakin University, Lilly, NHMRC and Australasian Society for Bipolar and Depressive Disorders (ASBDD)/Servier. MB has received Grant/Research Support from the NIH, Cooperative Research Centre, Simons Autism Foundation, Cancer Council of Victoria, Stanley Medical Research Foundation, Medical Benefits Fund, National Health and Medical Research Council, Medical Research Futures Fund, Beyond Blue, Rotary Health, A2 milk company, Meat and Livestock Board, Woolworths, Avant and the Harry Windsor Foundation, has been a speaker for Astra Zeneca, Lundbeck, Merck, Pfizer, and served as a consultant to Allergan, Astra Zeneca, Bioadvantex, Bionomics, Collaborative Medicinal Development, Lundbeck Merck, Pfizer and Servier. JAP reports grants from NHMRC during the conduct of the study; grants from Amgen, outside the submitted work.
(Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.)
